Related Experiment Videos
An Update on Myasthenic Crisis.
Shafiuddin Ahmed1, Jawad F Kirmani, Nazli Janjua
1Department of Neurology and Neurosciences, University of Medicine and Dentistry of New Jersey, Newark, NJ 07101, USA. jkirmani@hotmail.com.
Current Treatment Options in Neurology
|January 29, 2005
Summary
Myasthenia crisis, a severe form of myasthenia gravis, requires prompt mechanical ventilation. Plasma exchange may offer better outcomes than intravenous immunoglobulin for respiratory failure in these patients.
Area of Science:
- Neurology
- Critical Care Medicine
Background:
- Myasthenia gravis (MG) is a common neuromuscular junction disorder.
- Myasthenia crisis, characterized by respiratory failure needing mechanical ventilation, affects 15-20% of MG patients.
- Advances in ventilation, neurocritical care, and immunotherapy have improved myasthenic crisis prognosis.
Purpose of the Study:
- To review the current management strategies for myasthenia crisis.
- To highlight the importance of early respiratory support and novel treatment approaches.
Main Methods:
- Review of current literature on myasthenia crisis management.
- Discussion of intubation techniques and supportive care.
- Comparison of therapeutic options including plasma exchange and intravenous immunoglobulin.
Main Results:
- Early intubation and mechanical ventilation are crucial for managing myasthenia crisis.
- Orotracheal intubation and small bore duodenal tubes are favored for reducing aspiration risk.
- Plasma exchange may be more effective than intravenous immunoglobulin for respiratory failure, requiring further randomized trials.
Conclusions:
- Management of myasthenia crisis necessitates a tailored, individualized approach.
- While early respiratory support is key, the roles of immunosuppression and certain medications remain debated.
- Further research is needed to establish optimal treatment protocols, particularly comparing plasma exchange and IVIg.